Skip to main navigation Skip to search Skip to main content

A Phase 1 study of BMS-275183, a novel oral analogue of paclitaxel given on a daily schedule to patients with advanced malignancies

  • Elisabeth I. Heath
  • , Patricia LoRusso
  • , Suresh S. Ramalingam
  • , Ahmad Awada
  • , Merrill J. Egorin
  • , Tatiana Besse-Hamer
  • , Fatima Cardoso
  • , Manuel Valdivieso
  • , Teresa Has
  • , Leila Alland
  • , Xiaofei Zhou
  • , Chandra P. Belani

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A Phase 1 study of BMS-275183, a novel oral analogue of paclitaxel given on a daily schedule to patients with advanced malignancies'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science